135 related articles for article (PubMed ID: 32703610)
1. PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease.
Altinoz MA; Elmaci İ; Hacimuftuoglu A; Ozpinar A; Hacker E; Ozpinar A
Mol Aspects Med; 2021 Apr; 78():100871. PubMed ID: 32703610
[TBL] [Abstract][Full Text] [Related]
2. Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.
Altinoz MA; Ozpinar A; Ozpinar A; Hacker E
Metab Brain Dis; 2020 Jan; 35(1):1-9. PubMed ID: 31625071
[TBL] [Abstract][Full Text] [Related]
3. PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism.
Altinoz MA; Ozpinar A
Int Immunopharmacol; 2019 Apr; 69():245-256. PubMed ID: 30738994
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPARδ-ligand erucic acid in rotenone-induced Parkinson's disease model in zebrafish.
Ünal İ; Cansız D; Sürmen MG; Sürmen S; Sezer Z; Beler M; Üstündağ ÜV; Güzel E; Alturfan AA; Emekli-Alturfan E
Eur J Neurosci; 2023 Feb; 57(4):585-606. PubMed ID: 36564343
[TBL] [Abstract][Full Text] [Related]
5. Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis.
Altinoz MA; Bilir A; Elmaci İ
Chem Biol Interact; 2018 Oct; 294():107-117. PubMed ID: 30142312
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
[TBL] [Abstract][Full Text] [Related]
7. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective potential of erucic acid via inhibition of N2a cell lines and rotenone induced Parkinson's disease rat model.
Sharma B; Gupta P; Biswas L; Verma AK; Pasha AM; Thota P; Medhi B
Indian J Pharmacol; 2023; 55(6):376-384. PubMed ID: 38174534
[TBL] [Abstract][Full Text] [Related]
9. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
[TBL] [Abstract][Full Text] [Related]
10. Could dietary erucic acid lower risk of brain tumors? An epidemiological look to Chinese population with implications for prevention and treatment.
Altinoz MA
Metab Brain Dis; 2022 Dec; 37(8):2643-2651. PubMed ID: 35704146
[TBL] [Abstract][Full Text] [Related]
11. Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases.
Goyal A; Dubey N; Verma A; Agrawal A
Curr Mol Med; 2024; 24(4):419-427. PubMed ID: 37165502
[TBL] [Abstract][Full Text] [Related]
12. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D
Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867
[TBL] [Abstract][Full Text] [Related]
14. The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition.
Kino T; Rice KC; Chrousos GP
Eur J Clin Invest; 2007 May; 37(5):425-33. PubMed ID: 17461989
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPARδ attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells.
Lee WJ; Ham SA; Yoo H; Hwang JS; Yoo T; Paek KS; Lim DS; Han SG; Lee CH; Hong K; Seo HG
J Cell Biochem; 2018 Jul; 119(7):5609-5619. PubMed ID: 29388693
[TBL] [Abstract][Full Text] [Related]
17. PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress.
Ali F; Ali NS; Bauer A; Boyle JJ; Hamdulay SS; Haskard DO; Randi AM; Mason JC
Cardiovasc Res; 2010 Mar; 85(4):701-10. PubMed ID: 19903700
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
[TBL] [Abstract][Full Text] [Related]
20. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
